Estonia -
estoński -
Adama
mirador® forte
adama - emulsioonikontsentraat - asoksüstrobiin + tebukonasool - fungitsiidid
Estonia -
estoński -
Adama
mixin®
adama - suspo-emulsioon - florasulaam + fluroksüpüür - herbitsiidid
Estonia -
estoński -
Adama
tomahawk® 200 ec
adama - emulsioonikontsentraat - fluroksüpüür - herbitsiidid
Estonia -
estoński -
Adama
goltix® 700 sc
adama - uspensioonikontsentraat - metamitroon - herbitsiidid
Estonia -
estoński -
Adama
mistral® 700 wg
adama - vees dispergeeruvad graanulid - metribusiin - herbitsiidid
Estonia -
estoński -
Ravimiamet
tolfenamic acid tablett
famar a.v.e. pharmaceutical & cosmetic manufacturer famar s.a. anthoussa plant - tolfenaamhape - tablett - 200mg 10tk
Estonia -
estoński -
Ravimiamet
cerson tablett
belupo pharmaceuticals and cosmetics, inc. - nitrasepaam - tablett - 5mg 10tk
Unia Europejska -
estoński -
EMA (European Medicines Agency)
pylclari
curium pet france - piflufolastat (18f) - eesnäärmevähk - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
Estonia -
estoński -
Ravimiamet
mirtastad 30 mg õhukese polümeerikattega tablett
stada arzneimittel ag - mirtasapiin - õhukese polümeerikattega tablett - 30mg 1000tk; 30mg 100tk; 30mg 500tk; 30mg 20tk; 30mg 200tk; 30mg 150tk; 30mg 28tk; 30mg 90tk; 30mg 60tk; 30mg 350tk; 30mg 300tk; 30mg 40tk; 30mg 110tk; 30mg 250tk; 30mg 50tk; 30mg 98tk; 30mg 48tk